Free Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Europe Efsa will update ‘statement on CBD as a novel food’ by end of 2025 ...
  • New Mexico - United States Bill to ban synthetic cannabinoids in hemp products heads to governor ...
  • France Anses wants to reclassify CBD as presumed toxic for human reproduction ...
  • Denmark Government proposes law to make medical cannabis scheme permanent ...
  • Italy Association criticises hemp flower ban proposed in Security Bill ...
  • Germany No cannabis clubs approved yet in Bavaria ...
  • France Medical cannabis regulatory texts submitted to European Commission ...
  • Texas - United States Senate bill that would prohibit most hemp-derived cannabinoids moves to House ...
  • France Temporary-use authorisation for medical cannabis established ...
  • Ecuador New hemp regulation eases requirements to produce, cultivate and process ...
  • Moldova Contradiction in regulations could delay hemp cultivation ...
  • Germany Large-scale cannabis cultivation facility plans halted ...
News analysis

Industry associations lay out arguments against classifying CBD as a narcotic

Written by || 10th September 2020 || News analysis |

A group of industry associations say considering cannabinoid extracts such as CBD derived from hemp to be narcotics goes against the spirit of the UN Conventions on drugs
Read full article

Download the full news analysis

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

I'm already a subscriber

Freddie Dawson

Senior news editor
Freddie studied at King’s College, London and City University and worked for publications including The Times, The Malay Mail, PathfinderBuzz and Solar Summary before joining the CannIntelligence team. He has extensive experience in covering fast-moving consumer goods (FMCG), manufacturing and technological innovation.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Thanks for getting in touch with us

Please leave your enquiry and we will get back to you within 24 hours

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.